Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion type Assertion NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_head.
- NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion description "[Importantly, FET? cells retained their response to TGF-beta-mediated growth inhibition, and, like the parental FET cells, expression of a dominant negative TGF-beta type II receptor (DNRII) in FET? cells (FET?/DNRII) abrogated responsiveness to TGF-beta-induced growth inhibition and apoptosis under stress conditions in vitro and increased metastatic potential in an orthotopic model in vivo, which indicates metastasis suppressor activity of TGF-beta signaling in this model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_provenance.
- NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion evidence source_evidence_literature NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_provenance.
- NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion SIO_000772 23536895 NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_provenance.
- NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion wasDerivedFrom befree-2016 NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_provenance.
- NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_assertion wasGeneratedBy ECO_0000203 NP1064435.RAptFk9tUy6bId-zxAkM5L-xp9AW5vTEBB9B_Ymva6wuI130_provenance.